Loading
LH
LexaGene Holdings Inc. Stock: price and insider trades · Canada
LexaGene Holdings Inc.: what insiders have been doing
LexaGene Holdings Inc. is a listed company. Its directors and officers file their transactions with SEDI. LexaGene Holdings Inc. has had no insider filing for more than a year; the last one goes back to 29 June 2022.
Over the whole record (from 2022), the tally stands at 2 purchases and no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€14,005
2 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 29 June 2022
Declarations2 total
45,000 shares@ CA$0.13100.0% of flowCommon SharesTSXSEDI:3967990
Canonical exit: 27 Sept 2022 (T+90)
100,000 shares@ CA$0.13100.0% of flowCommon SharesTSXSEDI:3967962
Canonical exit: 27 Sept 2022 (T+90)
2 of 2 declarations
About LexaGene Holdings Inc.
LexaGene Holdings Inc. is a biotechnology company that develops genomic detection technologies to enhance clinical diagnostics. It is listed on the Toronto Stock Exchange (XTSE).
